Abstract
Copolymers of lactic (or lactide) and glycolic (or glycolide) acids (PLGAs) are among the most commonly used materials in biomedical applications, such as parenteral controlled drug delivery, due to their biocompatibility, predictable degradation rate, and ease of processing. Besides manufacturing variables of drug delivery vehicles, changes in PLGA raw material properties can affect product behavior. Accordingly, an in-depth understanding of polymer-related “critical quality attributes” can improve selection and predictability of PLGA performance. Here, we selected 19 different PLGAs from five manufacturers to form drug-free films, submillimeter implants, and microspheres and evaluated differences in their water uptake, degradation, and erosion during in vitro incubation as a function of L/G ratio, polymerization method, molecular weight, end-capping, and geometry. Uncapped PLGA 50/50 films from different manufacturers with similar molecular weights and higher glycolic unit blockiness and/or block length values showed faster initial degradation rates. Geometrically, larger implants of 75/25, uncapped PLGA showed higher water uptake and faster degradation rates in the first week compared to microspheres of the same polymers, likely due to enhanced effects of acid-catalyzed degradation from PLGA acidic byproducts unable to escape as efficiently from larger geometries. Manufacturer differences such as increased residual monomer appeared to increase water uptake and degradation in uncapped 50/50 PLGA films and poly(lactide) implants. This dataset of different polymer manufacturers could be useful in selecting desired PLGAs for controlled release applications or comparing differences in behavior during product development, and these techniques to further compare differences in less reported properties such as sequence distribution may be useful for future analyses of PLGA performance in drug delivery.
Graphical abstract
Similar content being viewed by others
Availability of data and materials
All data generated or analyzed during this study are included in this published article and its supplementary information files.
References
Park K, Skidmore S, Hadar J, Garner J, Park H, Otte A, Soh BK, Yoon G, Yu D, Yun Y. J Control Release. 2019;304:125–34.
Zhou J, Walker J, Ackermann R, Olsen K, Hong JKY, Wang Y, Schwendeman SP. Mol Pharm. 2020;17:1502–15.
Fredenberg S, Wahlgren M, Reslow M, Axelsson A. Int J Pharm. 2011;415:34–52.
Wang J, Wang BM, Schwendeman SP. J Control Release. 2002;82:289–307.
Kang J, Schwendeman SP. Mol Pharm. 2007;4:104–18.
Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Qin B, Schwendeman SP. Mol Pharm. 2020;17(11):4141–4151.
Farrar, D. Degradation rate of bioresorbable materials. Woodhead Publishing, 2008. 183-206.
Park TG. J Control Release. 1994;30:161–73.
Tracy MA, Ward KL, Firouzabadian L, Wang Y, Dong N, Qian R, Zhang Y. Biomaterials. 1999;20:1057–62.
Avgoustakis K. Encycl Biomater Biomed Eng. 2008;2259–69.
Lendlein A, Sisson A. Handbook of biodegradable polymers: isolation, synthesis. Characterization and applications: John Wiley & Sons; 2011.
Ren J. Biodegradable poly (lactic acid): Synthesis, modification, processing and applications. Springer Science & Business Media. 2011.
Braun D, Cherdron H, Rehahn M, Ritter H, Voit B. Polymer synthesis: Theory and practice: fundamentals, methods, experiments. Springer Science & Business Media. 2012.
Braun D, Cherdron H, Ritter H. Polymer synthesis: Theory and practice fundamentals, methods, experiments. Springer. 2001.
Chen X, Ooi CP. Acta Biomater. 2008;4:1046–56.
Badi N, Chan-Seng D, Lutz J. Macromol Chem Phys. 2013;214:135–42.
Li J, Stayshich RM, Meyer TY. J Am Chem Soc. 2011;133:6910–3.
Li J, Rothstein SN, Little SR, Edenborn HM, Meyer TY. J Am Chem Soc. 2012;134:16352–9.
Vey E, Rodger C, Booth J, Claybourn M, Miller AF, Saiani A. Polym Degrad Stab. 2011;96:1882–9.
Washington MA, Swiner DJ, Bell KR, Fedorchak MV, Little SR, Meyer TY. Biomaterials. 2017;117:66–76.
Shi NQ, Zhou J, Walker J, Li L, Hong KY, Olsen KF, Tang J, Ackermann R, Wang Y, Qin B. J Control Release. 2020;321:756-772.
Zhang Y, Sophocleous AM, Schwendeman SP. Pharm Res. 2009;26:1986–94.
Zhang Y, Schwendeman SP. J Control Release. 2012;162:119–26.
Zhu G, Mallery SR, Schwendeman SP. Nat Biotechnol. 2000;18:52–7.
Kang J, Schwendeman SP. Macromolecules. 2003;36:1324–30.
Hirota K, Doty AC, Ackermann R, Zhou J, Olsen KF, Feng MR, Wang Y, Choi S, Qu W, Schwendeman AS et al. J Control Release. 2016;244:302-313.
Doty AC, Zhang Y, Weinstein DG, Wang Y, Choi S, Qu W, Mittal S, Schwendeman SP. Eur J Pharm Biopharm. 2017;113:24–33.
Sun J, Walker J, Beck-Broichsitter M, Schwendeman SP. Drug Deliv Transl Res. 2022;12(3):720-729.
Kang J, Schwendeman SP. Biomaterials. 2002;23:239–45.
Witt C, Kissel T. Eur J Pharm Biopharm. 2001;51:171–81.
Hutchinson BJA, Furr FG. J Control Release. 1990;13:279–94.
Husmann M, Schenderlein S, Lück M, Lindner H, Kleinebudde P. Int J Pharm. 2002;242:277–80.
Bodmer D, Kissel T, Traechslin E. J Control Release. 1992;21(1–3):129–37.
Spenlehauer G, Vert M, Benoit JP, Boddaert A. Biomaterials. 1989;10:557–63.
Samadi N, Abbadessa A, Di Stefano A, Van Nostrum CF, Vermonden T, Rahimian S, Teunissen EA, Van Steenbergen MJ, Amidi M, Hennink WE. J Control Release. 2013;172:436–43.
Huang CL, Kumar S, Tan JJZ, Boey FYC, Venkatraman SS, Steele TWJ, Loo JSC. Polym Degrad Stab. 2013;98:619–26.
Alexis F. Polym Int. 2005;54:36–46.
Grizzi I, Garreau H, Li S, Vert M. Biomaterials. 1995;16:305–11.
Skidmore S, Hadar J, Garner J, Park H, Park K, Wang Y, Jiang XJ. J Control Release. 2019;300:174–84.
Grijpma DW, Nijenhuis AJ, Pennings AJ. Polymer (Guildf). 1990;31:2201–6.
Schliecker G, Schmidt C, Fuchs S, Wombacher R, Kissel T. Int J Pharm. 2003;266:39–49.
Gleadall A, Pan J, Kruft M-A, Kellomäki M. Acta Biomater. 2014;10:2233–40.
Bittner B, Ronneberger B, Zange R, Volland C, Anderson JM, Kissel T. J Microencapsul. 1998;15:495–514.
Hyon S, Jamshidi K, Ikada Y. Polym Int. 1998;46:196–202.
Shenderova A, Ding AG, Schwendeman SP. Macromolecules. 2004;37:10052–8.
Qian H, Wohl AR, Crow JT, Macosko CW, Hoye TR. Macromolecules. 2011;44:7132–40.
Masutani K, Kimura Y. Poly(lactic acid) Sci Technol Process Prop Addit Appl. 2014;1–36.
Washington MA, Balmert SC, Fedorchak MV, Little SR, Watkins SC, Meyer TY. Acta Biomater. 2018;65:259–71.
Funding
This study was supported by a fund from MilliporeSigma a Business of Merck KGaA (Darmstadt, Germany).
Author information
Authors and Affiliations
Contributions
Material preparation, data collection, and analysis were performed by Jennifer Walker. Data collection and analysis were also performed by Jason Albert, Desheng Liang, Jing Sun, Richard Schutzman, Cameron White, and Raj Kumar. Steven P Schwendeman, Moritz Beck-Broichsitter, Jennifer Walker, and Jason Albert contributed to study conception and design. All authors whose names appear on the submission approved the version to be published.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
13346_2022_1177_MOESM1_ESM.docx
Supplementary file1 Fig. 1 Lactic content remaining in 50/50 uncapped and end-capped PLGA films as a function of incubation time. (DOCX 93 KB)
Rights and permissions
About this article
Cite this article
Walker, J., Albert, J., Liang, D. et al. In vitro degradation and erosion behavior of commercial PLGAs used for controlled drug delivery. Drug Deliv. and Transl. Res. 13, 237–251 (2023). https://doi.org/10.1007/s13346-022-01177-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13346-022-01177-8